Journal article
Periprocedural Heparin Bridging in Patients Receiving Vitamin K Antagonists
Abstract
BACKGROUND: Periprocedural bridging with unfractionated heparin or low-molecular-weight heparin aims to reduce the risk of thromboembolic events in patients receiving long-term vitamin K antagonists. Optimal periprocedural anticoagulation has not been established.
METHODS AND RESULTS: MEDLINE, EMBASE, and Cochrane databases (2001-2010) were searched for English-language studies including patients receiving heparin bridging during interruption …
Authors
Siegal D; Yudin J; Kaatz S; Douketis JD; Lim W; Spyropoulos AC
Journal
Circulation, Vol. 126, No. 13, pp. 1630–1639
Publisher
Wolters Kluwer
Publication Date
September 25, 2012
DOI
10.1161/circulationaha.112.105221
ISSN
0009-7322